High mRNA Expression of LMO4, A BRCA1 Downregulator, Correlates with Better Prognosis in Erlotinib-Treated Non-Small-Cell Lung Cancer (NSCLC) Patients (P) with EGFR Mutations
Karachaliou, N., Costa, C., Gimenez-Capitan, A., Viteri, S., Gasco, A., Camps, C., Carcereny, E., Sureda, B. Massuti, Souglakos, J., Rosell, R.Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)34199-5
Date:
September, 2012
File:
PDF, 65 KB
2012